Applera Corp
Celera reports improved results for Q4 and FY2004
Published in Lab Law Weekly, August 27th, 2004
Celera Genomics Group (CRA), an Applera Corp. business, reported a net loss of $5.8 million, or $0.08 per share, for the fourth quarter of fiscal 2004 ended June 30, 2004, compared to a net loss of $19.4 million, or $0.27 per share, for the fourth quarter of fiscal 2003.
The fourth-quarter fiscal-2004 results included a $24.8 million pretax gain associated with the sale of the company's investment in Discovery Partners International, Inc., (DPII) and a non-cash pretax charge of $18.1 million, representing the estimated loss on the planned sale of Celera Genomics' Rockville, Maryland facility. These items reduced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2004-08-27)
More Articles from Lab Law Weekly
- American Bio Medica Corporation
Biotech company granted patents related to fluid sample device - BTG
Conductive keratoplasty patents to be commercialized - Cardiac Care
Elkins, West Virginia, joins list of communities losing cardiac rehab services - Children's Hospital Westmead
Routine childhood immunizations should not be compulsory - Chiron Corp.
Biotech names Ursula B. Bartels vice president and general counsel - CytoGenix, Inc.
DNA-expression company files for patents for antibacterials, antifungals - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
